If you have been reading about dihexa and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Glucose transporter type 4 (GLUT4), also known as solute carrier family 2, facilitated glucose transporter member 4, is a protein encoded, in humans, by the SLC2A4 gene. GLUT4 is the insulin-regulated glucose transporter found primarily in adipose tissues and striated muscle (skeletal and cardiac). GLUT4 is distinctive because it is predominantly stored within intracellular vesicles, highlighting the importance of its trafficking and regulation as a central area of research. The first evidence for this glucose transport protein was provided by David James in 1988. The gene that encodes GLUT4 was cloned and mapped in 1989. At the cell surface, GLUT4 permits the facilitated diffusion of circulating glucose down its concentration gradient into muscle and fat cells. Once within cells, glucose is rapidly phosphorylated by glucokinase in the liver and hexokinase in other tissues to form glucose-6-phosphate, which then enters glycolysis or is polymerized into glycogen. Glucose-6-phosphate cannot diffuse back out of cells, which also serves to maintain the concentration gradient for glucose to passively enter cells.
While in the healthy heart, waves of electrical impulses originate in the sinus node before spreading to the rest of the atria, the atrioventricular node, and finally the ventricles (referred to as a normal sinus rhythm), this normal rhythm can be disrupted. Abnormal heart rhythms or arrhythmias may be asymptomatic or may cause palpitations, blackouts, or breathlessness. Some types of arrhythmia such as atrial fibrillation increase the long term risk of stroke. Some arrhythmias cause the heart to beat abnormally slowly, referred to as a bradycardia or bradyarrhythmia. This may be caused by an abnormally slow sinus node or damage within the cardiac conduction system (heart block). In other arrhythmias the heart may beat abnormally rapidly, referred to as a tachycardia or tachyarrhythmia. These arrhythmias can take many forms and can originate from different structures within the heart—some arise from the atria (e.g. atrial flutter), some from the atrioventricular node (e.g. AV nodal re-entrant tachycardia) whilst others arise from the ventricles (e.g. ventricular tachycardia). Some tachyarrhythmias are caused by scarring within the heart (e.g. some forms of ventricular tachycardia), others by an irritable focus (e.g. focal atrial tachycardia), while others are caused by additional abnormal conduction tissue that has been present since birth (e.g. Wolff-Parkinson-White syndrome). The most dangerous form of heart racing is ventricular fibrillation, in which the ventricles quiver rather than contract, and which if untreated is rapidly fatal.
== N == Robert Nalbandyan (1937–2002), Armenian protein chemist known for discovery of photosynthetic protein plantacyanin Sergey Nametkin (1976–1950), Russian organic chemist known the cracking of petrochemicals, and rearrangement of camphenes Louise Natrajan (PhD 2003), British chemist who ortks on actinide chemistry and luminescence spectroscopy Giulio Natta (1903–1979), Italian chemical engineer worked on high density polymers, 1963 Nobel Prize in Chemistry Costin Nenițescu (1902–1970), Romanian chemist who studied the oxidation of open-chain and aromatic hydrocarbons with chromic acid and chromic oxychloride Antonio Neri (1576–1614), Florentine priest, author of L’Arte Vetraria (The Art of Glass), the first general treatise on the systematics of glassmaking Walther Nernst (1864–1941), German physical chemist whose heat theorem led the way to the third law of thermodynamics, 1920 Nobel Prize in Chemistry John Alexander Reina Newlands (1837–1898), British analytical chemist, precursor of the periodic order of elements William Nicholson (1753–1815), British chemist and civil engineer, the first to achieve electrolysis Kyriacos Costa Nicolaou (born 1946), Cypriot-American chemist known for total synthesis of natural products Julius Nieuwland (1878–1936), Belgian and American prirest and chemist who worked on synthetic rubber Mathias Nilsson, Swedish physical and analytical chemist concerned with liquid NMR spectroscopy Alfred Nobel (1833–1896), Swedish chemist who invented dynamite and established the Nobel Prizes Ronald George Wreyford Norrish (1897–1978), British chemist known for flash photolysis and the Norrish reaction, 1967 Nobel Prize in Chemistry John Howard Northrop (1891–1987), American biochemist known for isolation, crystallization, and study of enzymes, proteins, and viruses; 1946 Nobel Prize in Chemistry Ryōji Noyori (born 1938), Japanese chemist, 2001 Nobel Prize in Chemistry for the study of chirally catalyzed hydrogenations Ralph Nuzzo (born 1954), American materials chemist known for work on the chemistry of materials, including processes that occur at surfaces and interfaces
Sources: en.wikipedia.org
Vance and Gibbs clash during this span, prompting a cold war between them, which ends with a détente in "Agent Afloat" at the start of season six. However, the two again clash later on because Gibbs feels he cannot fully trust Vance, though he cannot identify a specific reason why. Vance spearheads the investigation into Shepard's death and is angered greatly when he is not kept in the loop by Gibbs and Mike Franks, who ultimately manipulate the situation to exonerate Shepard from her past failure, not what Vance had in mind. After Shepard's death, and possibly before, he lobbies the Secretary of the Navy hard to take over NCIS, as seen in "Cloak", but in "Semper Fidelis", the Secretary informs Gibbs of a major operation that will require Vance to serve as its head and that NCIS and the Navy will need Gibbs and Vance to get along. Things come to a head in "Aliyah", when Gibbs accuses Vance of selling out his team to Mossad Director Eli David. Vance responds that Ziva is a plant, used to get Mossad a foothold in NCIS through Gibbs. Vance also reveals that he knows about the true story of the death of Ari Haswari. After this, the two of them realize that circumstances will prove one of them right. At the start of season seven, Vance approves Ziva's transfer to NCIS, proving that Gibbs was right and Ziva is loyal to NCIS. Despite his professional attitude toward Gibbs' team, Vance shows that he does care about them when Alejandro Rivera threatens Abby in "Spider and the Fly".
Aberrant activation of Akt, either via PI3K or independently of PI3K, is often associated with malignancy. Studies have identified gene amplification of the Akt isoforms in many types of cancer, including glioblastoma, ovarian, pancreatic and breast cancers. Akt is also up-regulated in terms of mRNA production in breast and prostate cancer. Functional inactivation of PTEN, the major PI3K antagonist, can occur in cancer cells by point mutation, gene deletion or epigenetic mechanisms. Mutation in the pathway can also affect receptor tyrosine kinases, growth factors, Ras and the PI3K p110 subunit, leading to abnormal signaling activity. Therefore, many of the proteins in the pathway are targets for cancer therapeutics. In addition to its effects on cell survival and cell cycle progression, the PI3K-Akt pathway promotes other characteristics of cancer cells. Hyperactivity of the pathway promotes the epithelial-mesenchymal transition (EMT) and metastasis due to its effects on cell migration.
Double-stranded RNA (dsRNA) is RNA with two complementary strands, similar to the DNA found in all cells, but with the replacement of thymine by uracil and the adding of one oxygen atom. dsRNA forms the genetic material of some viruses (double-stranded RNA viruses). Double-stranded RNA, such as viral RNA or siRNA, can trigger RNA interference in eukaryotes, as well as interferon response in vertebrates. In eukaryotes, double-stranded RNA (dsRNA) plays a role in the activation of the innate immune system against viral infections. In the late 1970s, it was shown that there is a single stranded covalently closed, i.e. circular form of RNA expressed throughout the animal and plant kingdom (see circRNA). circRNAs are thought to arise via a "back-splice" reaction where the spliceosome joins a upstream 3' acceptor to a downstream 5' donor splice site. So far the function of circRNAs is largely unknown, although for few examples a microRNA sponging activity has been demonstrated.
The latter may be involved in the effectiveness of propranolol in the treatment of migraine at high doses. (–)-Propranolol is not a silent antagonist of the serotonin 5-HT1A receptor but is instead a very weak partial agonist of the receptor. Both enantiomers of propranolol have a local anesthetic (topical) effect, which is normally mediated by blockade of voltage-gated sodium channels. Studies have demonstrated propranolol's ability to block cardiac, neuronal, and skeletal voltage-gated sodium channels, accounting for its known membrane stabilizing effect and antiarrhythmic and other central nervous system effects.
Sources: en.wikipedia.org
=== Liquid crystals, colloidal glasses, and hydrogels === Owed to their anisotropic shape and surface charge, nanocelluloses (mostly rigid CNCs) have a high excluded volume and self-assemble into cholesteric liquid crystals beyond a critical volume fraction. Nanocellulose liquid crystals are left-handed due to the right-handed twist on particle level. Nanocellulose phase behavior is susceptible to ionic charge screening. An increase in ionic strength induces the arrest of nanocellulose dispersions into attractive glasses. At further increasing ionic strength, nanocelluloses aggregate into hydrogels. The interactions within nanocelluloses are weak and reversible, wherefore nanocellulose suspensions and hydrogels are self-healing and may be applied as injectable materials or 3D printing inks.
Diverse perspectives on well-being are found in religious and other traditional belief systems, where well-being often serves as a goal of spiritual practice. In various traditional forms of Hinduism, the highest kind of well-being is not determined by objective external conditions. Instead, it depends primarily on experiential knowledge of the self, brought about through practices like self-inquiry and meditation. Buddhism identifies suffering as a central aspect of all existence. It aims to produce well-being by eliminating the causes of suffering, such as desire and ignorance, achieved through the practice of Buddhist virtues, like compassion, loving-kindness, and equanimity. From the perspective of Confucianism, well-being consists in virtuous activity as a process leading to sagehood and is associated with harmonious relationships and social responsibility. According to Taoism, a life high in well-being is characterized by effortless action that is in harmony with the Tao—the natural way of the universe—and guided by spontaneous dispositions. The Christian tradition holds that the personal connection to God is a central factor of well-being, which may manifest in virtuous activity or contemplation of God. According to the teachings of Islam, well-being is achieved by dedicating one's life as much as possible to worshiping Allah and fulfilling His will, as expressed in the Quran. Well-being is also a topic in various biological sciences with a focus on physiological factors. Research from twin studies suggests that genetic composition is an impactful determinant.
=== Treatment of depressive disorders === The addition of triiodothyronine to existing treatments such as SSRIs is one of the most widely studied augmentation strategies for refractory depression, however success may depend on the dosage of T3. A long-term case series study by Kelly and Lieberman of 17 patients with major refractory unipolar depression found that 14 patients showed sustained improvement of symptoms over an average timespan of two years, in some cases with higher doses of T3 than the traditional 50 μg required to achieve therapeutic effect, with an average of 80 μg and a dosage span of 24 months; dose range: 25–150 μg. The same authors published a retrospective study of 125 patients with the two most common categories of bipolar disorders II and NOS whose treatment had previously been resistant to an average of 14 other medications. They found that 84% experienced improvement and 33% experienced full remission over a period of an average of 20.3 months (standard deviation of 9.7). None of the patients experienced hypomania while on T3.
=== Microbead-based immobilization === Microbead-based immobilization is a modular technique in that it allows the investigator to decide whether they wish to fish for protein targets from the proteome or drug-like compounds from chemical libraries. The macroscopic properties of microbeads make them amenable to relatively low labor enrichment applications, since they are easily to visualize and their bulk mass is readily removable protein solutions. Microbeads were historically made of inert polymers, such as agarose and dextran, that are functionalized to attach a bait of choice. In the case of using proteins as bait, amine functional groups are common linkers to facilitate attachment. More modern approaches have benefitted from the popularization of dynabeads, a type of magnetic microbead, which enable magnetic separation of bead-immobilized analytes from treated samples. Magnetic beads exhibit superparamagnetic properties, which make them very easy to remove from solution using an external magnet. In a simplified workflow, magnetic beads are used to immobilize a protein target, then the beads are mixed with a chemical library to screen for potential ligands. High-affinity ligands bind to the immobilized target and resist removal by washing, so they are enriched in the sample. Conversely, a ligand of interest can be immobilized and screened against proteome proteins by incubation with a lysate.
=== Precision Medicine === The protease modulatory web represents opportunities to identify novel biomarkers for disease and targets for drug design. Proteolytic processed N-termini have been proposed as potential biomarkers as disease specific proteolysis has been well studied in pathologies such as inflammation and cancer. Contributions to degradomics have identified numerous characterized and novel protease substrates and continue to lead to speculation of previously unknown protease targets. More recently, proteolytic signatures of cell death have been found using N-terminomic techniques on chemotherapy patient plasma samples. Advancements in SRM and MRM clinical assays also allow for analyzing proteolytic signature biomarkers in patient samples and can be complemented by PSP quantification. Deciphering these networks will aid drug design in understanding which substrates perform useful roles versus harmful ones to determine which should be targeted by drugs.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
Typical storage is at -20 °C in a desiccated container protected from light. Repeated freeze-thaw cycles are usually minimized to reduce degradation. Specific conditions should follow the supplier’s documentation.